Skip to content

Effect of 0.12% Chlorhexidine mouthwash and 5% Malva sylvestris solution on dental plaque and gingival inflammation

Antiplaque and antigingivitis efficacy of 0.12% Chlorhexidine mouthwash and 5% Malva sylvestrais: A randomized crossover clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-8vyxcfk
Enrollment
Unknown
Registered
2023-08-22
Start date
2023-03-08
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingivitis

Interventions

This will be a double-blind, randomized crossover clinical trial, in which individuals will be randomly assigned to two different treatments: daily mouthwash with a 0.12% chlorhexidine digluconate bas
CASARIN et al., 2019). In addition, a cross-sectional design was also considered, a power of 80%, a sign

Sponsors

Universidade Federal de Pelotas
Lead Sponsor
Universidade Federal de Pelotas
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: systemically healthy; both sex; over 18-year-old; with more than 19 teeth present

Exclusion criteria

Exclusion criteria: Presenc of allergies to the components/products used (chlorhexidine digluconate 0.12%, Malva sylvestris extract 5%); use of 0.12% chlorhexidine digluconate or other mouthwash in the last 21 days; use of fixed and/or removable prostheses; being under orthodontic treatment; presence of caries lesion; presence of esthetic or poorly adapted restorations; presence of lesions on the oral mucosa; presence of active infectious focus (endodontic abscesses); presence of marginal gingival bleeding more than 10%; history of periodontitis (interproximal attachment loss more than 3mm in two or more non-adjacent teeth); presence of diabetes or immunosuppression; pregnant or breast-feeding patients; smokers; use of local or systemic antimicrobials in the last 90 days.

Design outcomes

Primary

MeasureTime frame
It is expected to find a decrease in the plaque index after a period of four days of use of the product, verified by means of the Quigley-Hein plaque index modified by Turesky (Turesky et al., 1970), from the observation of a difference mean scores after the intervention was applied.

Secondary

MeasureTime frame
It is expected to find a decrease in the gingival index after a period of four days of use of the product, verified through the Modified Gingival Bleeding Index, based on the observation of an occurrence of the average of scores after the pre- and post-intervention measurements have been performed.;A questionnaire will be applied where all participants will be able to express their opinion regarding the product used for mouthwash. Subjects will be asked about product taste, taste change, wearing comfort, taste duration, and perceived plaque control. Based on SLOT et al. (2010), the Visual Analog Scale (VS) will be used. This scale is represented by an uncalibrated line of 10 cm in length, where participants will mark a point referring to the negative answer (0) on the left and referring to the positive answer (10) on the right end of the line (SLOT et al., 2010 ). It is expected that there will be no change in the appreciation and perception of individuals after using the substances used.

Countries

Brazil

Contacts

Public ContactMaísa Casarin

Universidade Federal de Pelotas

maisa.66@hotmail.com+55(55)999393865

Outcome results

None listed

Source: REBEC (via WHO ICTRP)